M. Myers

First name
M.
Middle name
W.
Last name
Myers
Myers, M. W., & Jick, H. (1998). Terfenadine and risk of acute liver disease. Br J Clin Pharmacol.
Jick, H., Jick, S. S., Gurewich, V., Myers, M. W., & Vasilakis, C. (1995). Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet.
Jick, H., Myers, M. W., & Dean, A. D. (1995). The risk of sulfasalazine- and mesalazine-associated blood disorders. Pharmacotherapy.
Jick, S. S., Stender, M., & Myers, M. W. (1999). Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care.
Jick, S. S., Myers, M. W., & Jick, H. (1999). Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components. Lancet. http://doi.org/10.1016/s0140-6736(99)01014-4
Derby, L. E., Myers, M. W., & Jick, H. (1999). Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke. Br J Clin Pharmacol.
Myers, M. W., Vasilakis, C., Kaufman, M. R., & Jick, H. (2000). Antihypertensive drugs and the risk of idiopathic aplastic anaemia. Br J Clin Pharmacol.
Kaye, J. A., Myers, M. W., & Jick, H. (2001). Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiology.
Seshadri, S., Zornberg, G. L., Derby, L. E., Myers, M. W., Jick, H., & Drachman, D. A. (2001). Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol.